N/A
N=359
Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members
Gastrointestinal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03611309 ↗Enrolled (actual)
359
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Patient Quality of Life Patient Quality of Life 12 Weeks After Surgery — 138.54; 136.90 score on a scale — p=.623
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Surgeon-palliative care team co management (Other); Surgeon team alone management (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Aug 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Quality of Life Patient Quality of Life 12 Weeks After Surgery |
138.54; 136.90 | .623 |
| SECONDARY Patient Mood Symptoms Assessment 12 Weeks After Surgery |
-0.50; -0.43; -0.07; -0.07 | .555 |
| SECONDARY Patient Palliative Symptoms Assessment |
— | — |
| SECONDARY Patient Spiritual Assessment 12 Weeks After Surgery |
35.90; 35.89 | .997 |
| SECONDARY Patient Prognostic Awareness Assessment Assessment 12 Weeks After Surgery |
70; 80; 13; 11; 6; 3 | .484 |
| SECONDARY Patient Mortality up to 6 Months |
164; 156; 7; 6 | — |
| SECONDARY Caregiver Mood Symptom Assessment at 12 Weeks After Surgery |
0.32; 0.33; 0.27; 0.23 | — |
| SECONDARY Caregiver Burden Measurement 12 Weeks After Surgery |
6.50; 11.50 | .531 |
| SECONDARY Caregiver Spiritual Measure at 12 Weeks |
34.06; 33.72 | .871 |
| SECONDARY Caregiver Prognostic Awareness Assessment at 12 Weeks |
77; 83; 12; 7; 0; 3 | .770 |
Summary
The study goal is to compare surgeon-palliative care team co-management, versus surgeon alone management, of patients and family members preparing for major upper gastrointestinal cancer surgery. The study also aims to explore, using qualitative methods, the impact of surgeon-palliative care team co-management versus surgeon alone management on the perioperative care experience for patients, family members, surgeons, and palliative care clinicians.
Eligibility Criteria
Inclusion Criteria
- 18 years of age and must be able to give informed consent.
- Diagnosed with pancreatic cancer or hepatocellular cancer or esophageal cancer or gastric cancer and/or cholangio carcinomas
- Non emergent, upper gastrointestinal cancer related surgery with a goal of primary resection of the tumor- optimal surgical goal is cure, not merely disease palliation.
- One companion per patient will be allowed to participate. In addition, to being identified by the patient at being a key caregiver throughout the surgery period, these companions must be able to give informed consent and at least 18 years of age.
Exclusion Criteria
- No previous involvement of palliative care providers in their care course
Data sourced from ClinicalTrials.gov (NCT03611309). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.